Developing Next Generation Gene Therapy Vectors for the Treatment Of Rare Genetic Diseases
Time: 9:30 am
day: Day One
Details:
- Capsid, transgene, and process optimization for AAV gene therapy candidates
- Assessing process and product quality impact on potency, kinetics, and durability
- Selecting appropriate ex vivo and in vivo models to predict clinical safety and translatability
